Treatment with charged particles beams: Hadrontherapy part I - Physical basis and clinical experience of treatment with protons;Le traitement par faisceaux de particules: Hadronthérapie partie I - Bases physiques et expérience clinique de la protonthérapie

Cancer/Radiotherapie

Volumn 7, Issue 5, 2003, Pages 321-339

  Noel G ^a   Feuvret, L ^a   Ferrand, R ^a   Mazeron, J J ^a,b  

^a Ctr de Protontherapie d'Orsay   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Hadrontherapy; Particle beam therapy; Proton beams; Review

Indexed keywords

PROTON;

ARTERIOVENOUS MALFORMATION; BEAM THERAPY; CANCER RADIOTHERAPY; CHONDROSARCOMA; CHOROID MELANOMA; CLINICAL TRIAL; DIFFUSION; ESOPHAGUS CANCER; GLIOBLASTOMA; GLIOMA; HUMAN; MAXILLA SINUS CANCER; MENINGIOMA; NEURILEMOMA; PELVIS CANCER; PHOTON; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; RADIATION SCATTERING; RECTUM CANCER; REVIEW; TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0142025245     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(03)00044-1     Document Type: Short Survey

References (105)

1. Amin-Hanjani S, Ogilvy CS, Candia GJ, Lyons S, Chapman PH. Stereotactic radiosurgery for cavernous malformations: Kjellberg's experience with proton beam therapy in 98 cases at the Harvard Cyclotron. Neurosurgery 1998;42:1229-36.
2. Archambeau JO, Slater JD, Slater JM, Tangeman R. Role for proton beam irradiation in treatment of pediatric CNS malignancies. Int J Radiat Oncol Biol Phys 1992;22:287-94.
3. Austin-Seymour M, Munzenrider J, Goitein M, Verhey L, Urie M, Gentry R. et al. Fractionated proton radiation therapy of chordoma and low-grade chondrosarcoma of the base of the skull. J Neurosurg 1989;70:13-7.
4. Austin-Seymour M, Munzenrider J, Linggood R, Goitein M, Verhey L, Urie M, et al. Fractionated proton radiation therapy of cranial and intracranial tumors. Am J Clin Oncol 1990;13:327-30.
5. Austin JP, Urie MM, Cardenosa G, Munzenrider JE. Probable causes of recurrence in patients with chordoma and chondrosarcoma of the base of skull and cervical spine. Int J Radiat Oncol Biol Phys 1993;25:439-44.
6. Baumert BG, Lomax AJ, Miltchev V, Davis JB. A comparison of dose distributions of proton and photon beams in stereotactic conformal radiotherapy of brain lesions. Int J Radiat Oncol Biol Phys 2001;49:1439-49.
7. Benk V, Liebsch NJ, Munzenrider JE, Efird J, McManus P, Suit H. Base of skull and cervical spine chordomas in children treated by high-dose irradiation. Int J Radiat Oncol Biol Phys 1995;31:577-81.
8. Benk V, Liebsch NJ, Munzenrider JE, Efird J, McManus P, Suit H. Base of skull and cervical spine chordomas in children treated by high-dose irradiation. Int J Radiat Oncol Biol Phys 1995;31:577-81.
9. Benk VA, Adams JA, Shipley WU, Urie MM, McManus PL, Efird JT, et al. Late rectal bleeding following combined X-ray and proton high-dose irradiation for patients with stages T3-T4 prostate carcinoma. Int J Radiat Oncol Biol Phys 1993;26:551-7.
10. Berson AM, Castro JR, Petti P, Phillips TL, Gauger GE, Gutin P, et al. Charged particle irradiation of chordoma and chondrosarcoma of the base of skull and cervical spine: the Lawrence Berkeley Laboratory experience. Int J Radiat Oncol Biol Phys 1988;15:559-65.
11. Blomquist E, Carlsson J. Strategy for planned radiotherapy of malignant gliomas: postoperative treatment with combinations of high-dose proton irradiation and tumor seeking radionuclides. Int J Radiat Oncol Biol Phys 1992;22:259-63.
12. Boisserie G, Hasboun D. [Use of multimodality imagery in radiotherapy]. Cancer Radiother. 200; 5 Suppl 1:15s-35s.
13. Brown AP, Urie MM, Chisin R, Suit HD. Proton therapy for carcinoma of the nasopharynx: a study in comparative treatment planning. Int J Radiat Oncol Biol Phys 1989;16:1607-14.
14. Bush DA, Slater JD, Bonnet R, Cheek GA, Dunbar RD, Moyers M, et al. Proton-beam radiotherapy for early-stage lung cancer. Chest 1999;116:1313-9.
15. Castro JR, Linstadt DE, Bahary JP, Petti PL, Daftari I, Collier JM, et al. Experience in charged particle irradiation of tumors of the skull base: 1977-1992. Int J Radiat Oncol Biol Phys 1994;29:647-55.
16. Cella L, Lomax A, Miralbell R. Potential role of intensity modulated proton beams in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 2001;49:217-23.
17. Chu WT, Ludewigt BA, Renner TR. Instrumentation for treatment of cancer using proton and light-ion beams. Rev Sci Instrum 1993;64:2055-122.
18. Courdi A, Caujolle JP, Grange JD, Diallo-Rosier L, Sahel J, Bacin F, et al. Results of proton therapy of uveal melanomas treated in Nice. Int J Radiat Oncol Biol Phys 1999;45:5-11.
19. Cozzi L, Fogliata A, Lomax A, Bolsi A. A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours. Radiother Oncol 2001;61:287-97.
20. Debus J, Hug EB, Liebsch NJ, O'Farrel D, Finkelstein D, Efird J, et al. Brainstem tolerance to conformal radiotherapy of skull base tumors. Int J Radiat Oncol Biol Phys 1997;39:967-75.
21. Desjardins L, Levy C, D'hermies F, Frau E, Schlienger P, Habrand JL, et al. Résultats préliminaires de la protonthérapie du mélanome de la choroïde au centre de protonthérapie d'Orsay (CPO) : les 464 premiers cas. Cancer Radiother 1997;1:222-6.
22. Dubray B, Giraud P, Beaudre A. Glossaire de la radiothérapie conformationnelle. Cancer Radiother 1999;3:360-6.
23. Egger E, Schalenbourg A, Zografos L, Bercher L, Boehringer T, Chamot L, et al. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. Int J Radiat Oncol Biol Phys 2001;51:138-47.
24. Fitzek MM, Thornton AF, Harsh G, Rabinov JD, Munzenrider JE, Lev M, et al. Dose-escalation with proton/photon irradiation for Daumas-Duport lower grade glioma: results of an institutional phase I/II trial. Int J Radiat Oncol Biol Phys 2001;51:131-7.
25. Fitzek MM, Thornton AF, Rabinov JD, Lev MH, Pardo FS, Munzenrider JE, et al. Accelerated fractionated proton-photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial. J Neurosurg 1999;91:251-60.
26. Forsyth PA, Cascino TL, Shaw EG, Scheithauer BW, O'Fallon JR, Dozier JC, et al. Intracranial chordomas: a clinicopathological and prognostic study of 51 cases. J Neurosurg 1993;78:741-7.
27. Fuller DB, Bloom JG. Radiotherapy for chordoma. Int J Radiat Oncol Biol Phys 1988;15:331-9.
28. Fuss M, Hug EB, Schaefer RA, Nevinny-Stickel M, Miller DW, Slater JM, et al. Proton radiation therapy (PRT) for pediatric optic pathway gliomas: comparison with 3D planned conventional photons and a standard photon technique. Int J Radiat Oncol Biol Phys 1999;45:1117-26.
29. Gademann G, Wannenmacher M. Charged particle therapy to pediatric tumors of the retroperitoneal region: a possible indication. Int J Radiat Oncol Biol Phys 1992;22:375-81.
30. Gay E, Sekhar LN, Rubinstein E, Wright DC, Sen C, Janecka IP, et al. Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients. Neurosurgery 1995;36:887-96.
31. Glosser G, McManus P, Munzenrider J, Austin-Seymour M, Fullerton B, Adams J, et al. Neuropsychological function in adults after high dose fractionated radiation therapy of skull base tumors. Int J Radiat Oncol Biol Phys 1997;38:231-9.
32. Gragoudas ES, Lane AM, Regan S, Li W, Judge HE, Munzenrider JE, et al. A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma. Arch Ophthalmol 2000;118:773-8.
33. Gudjonsson O, Blomquist E, Nyberg G, Pellettieri L, Montelius A, Grusell E. et al. Stereotactic irradiation of skull base meningiomas with high energy protons. Acta Neurochir (Wien) 1999;141:933-40.
34. Habrand JL, Austin-Seymour M, Birnbaum S, Wray S, Carroll R, Munzenrider J, et al. Neurovisual outcome following proton radiation therapy. Int J Radiat Oncol Biol Phys 1989;16:1601-6.
35. Habrand JL, Mammar H, Ferrand R, Pontvert D, Bondiau PY, Kalifa C, et al. Proton beam therapy (PT) in the management of CNS tumors in childhood. Strahlenther Onkol 1999;175(Suppl 2):91-4.
36. Halperin EC. Why is female sex an independent predictor of shortened overall survival after proton-photon radiation therapy for skull base chordomas? Int J Radiat Oncol Biol Phys 1997;38:225-30.
37. Harsh GR, Thornton AF, Chapman PH, Bussiere MR, Rabinov JD, Loeffler JS. Proton beam stereotactic radiosurgery of vestibular schwannomas. Int J Radiat Oncol Biol Phys 2002;54:35-44.
38. Hug EB, Adams J, Fitzek M, de Vries A, Munzenrider JE. Fractionated, three-dimensional, planning-assisted proton-radiation therapy for orbital rhabdomyosarcoma: a novel technique. Int J Radiat Oncol Biol Phys 2000;47:979-84.
39. Hug EB, DeVries A, Thornton AF, Munzenride JE, Pardo FS, Hedley-Whyte ET, et al. Management of atypical and malignant meningiomas: role of high-dose, 3D conformal radiation therapy. J Neurooncol 2000;48:151-60.
40. Hug EB, Fitzek MM, Liebsch NJ, Munzenrider JE. Locally challenging osteo- and chondrogenic tumors of the axial skeleton: results of combined proton and photon radiation therapy using three-dimensional treatment planning. Int J Radiat Oncol Biol Phys 1995;31:467-76.
41. Hug EB, Loredo LN, Slater JD, DeVries A, Grove RI, Schaefer RA, et al. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg 1999;91:432-9.
42. Hug EB, Muenter MW, Adams JA, de Vries A, Rosenberg AE, Munzenrider JE. 3-D-conformal radiation therapy for pediatric giant cell tumors of the skull base. Strahlenther Onkol 2002;178:239-44.
43. Hug EB, Muenter MW, Archambeau JO, DeVries A, Liwnicz B, Loredo LN, et al. Conformal proton radiation therapy for pediatric low-grade astrocytomas. Strahlenther Onkol 2002;178:10-7.
44. Hug EB, Nevinny-Stickel M, Fuss M, Miller DW, Schaefer RA, Slater JD. Conformal proton radiation treatment for retroperitoneal neuroblastoma: introduction of a novel technique. Med Pediatr Oncol 2001;37:36-41.
45. Hug EB, Slater JD. Proton radiation therapy for pediatric malignancies: status report. Strahlenther Onkol 1999;175(Suppl 2):89-91.
46. Hug EB, Slater JD. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. Neurosurg Clin N Am 2000;11:627-38.
47. ICRP. Recommendations of the International Commission on Radiobiological Protection. Publication 60. Annals of the ICRP, 21. Oxford: Pergamon Press; 1991. p. 1-3.
48. Isacsson U, Montelius A, Jung B, Glimelius B. Comparative treatment planning between proton and X-ray therapy in locally advanced rectal cancer. Radiother Oncol 1996;41:263-72.
49. Jiang GL, Tucker SL, Guttenberger R, Peters LJ, Morrison WH, Garden AS, et al. Radiation-induced injury to the visual pathway. Radiother Oncol 1994;30:17-25.
50. Keisch ME, Garcia DM, Shibuya RB. Retrospective long-term follow-up analysis in 21 patients with chordomas of various sites treated at a single institution. J Neurosurg 1991;75:374-7.
51. Kim J, Munzenride JE, Maas A, Finkelstein D, Liebsch N, Hug E, et al. Optic neuropathy following combined proton and photon radiotherapy for base of skull tumors. Int J Radiat Oncol Biol Phys 1997;39:272 (abs. 2064).
52. Kjellberg RN, Hanamura T, Davis KR, Lyons SL, Adams RD. Braggpeak proton-beam therapy for arteriovenous malformations of the brain. N Engl J Med 1983;309:269-74.
53. Levin CV. Potential for gain in the use of proton beam boost to the para-aortic lymph nodes in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1992;22:355-9.
54. Lin R, Hug EB, Schaefer RA, Miller DW, Slater JM, Slater JD. Conformal proton radiation therapy of the posterior fossa: a study comparing protons with three-dimensional planned photons in limiting dose to auditory structures. Int J Radiat Oncol Biol Phys 2000;48:1219-26.
55. Lin R, Slater JD, Yonemoto LT, Grove RI, Teichman SL, Watt DK, et al. Nasopharyngeal carcinoma: repeat treatment with conformal proton therapy-dose- volume histogram analysis. Radiology 1999;213:489-94.
56. Lomax AJ, Bortfeld T, Goitein G, Debus J, Dykstra C, Tercier PA, et al. A treatment planning inter-comparison of proton and intensity modulated photon radiotherapy. Radiother Oncol 1999;51:257-71.
57. Lumbroso L, Levy C, Plancher C, Frau E, D'hermies F, Schlienger P, et al. Results of proton beam irradiation for treatment of choroidal melanoma. J Fr Ophtalmol 2002;25:290-7.
58. Mark RJ, Tran LM, Sercarz J, Fu YS, Calcaterra TC, Parker RG. Chondrosarcoma of the head and neck. The UCLA experience, 1955-1988. Am J Clin Oncol 1993;16:232-7.
59. Marucci L, Niemierko A, Liebsch N, Aboubaker F, Liu MCC, Munzenrider JE. Spinal cord tolerance to high dose fractionated 3D conformal proton-photon irradiation as evaluated by equivalent uniform dose and dose volume histogram analysis. Radiother Oncol 2002;64 (suppl. 1):S55 (abstract 167).
60. Mazeron JJ, Simon JM, Noel G, Proudhom MA, Renard A. Radiotherapy of brain astrocytomas and oligodendrogliomas of the adult. Cancer Radiother 2000;4(Suppl 1):53s-66s.
61. McAllister B, Archambeau JO, Nguyen MC, Slater JD, Loredo L, Schulte R, et al. Proton therapy for pediatric cranial tumors: preliminary report on treatment and disease-related morbidities. Int J Radiat Oncol Biol Phys 1997;39:455-60.
62. Miralbell R, Cella L, Weber D, Lomax A. Optimizing radiotherapy of orbital and paraorbital tumors: intensity-modulated X-ray beams vs. intensity-modulated proton beams. Int J Radiat Oncol Biol Phys 2000;47:1111-9.
63. Miralbell R, Crowell C, Suit HD. Potential improvement of three dimension treatment planning and proton therapy in the outcome of maxillary sinus cancer. Int J Radiat Oncol Biol Phys 1992;22:305-10.
64. Miralbell R, Linggood RM, De La MS, Convery K, Munzenrider JE, Mirimanoff RO. The role of radiotherapy in the treatment of subtotally resected benign meningiomas. J Neurooncol 1992;13:157-64.
65. Miralbell R, Lomax A, Bortfeld T, Rouzaud M, Carrie C. Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuroectodermal tumors: reduction of the supratentorial target volume. Int J Radiat Oncol Biol Phys 1997;38:477-84.
66. Miralbell R, Lomax A, Cella L, Schneider U. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys 2002;54:824-9.
67. Miralbell R, Lomax A, Russo M. Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuroectodermal tumors: spinal theca irradiation. Int J Radiat Oncol Biol Phys 1997;38:805-11.
68. Munzenrider J, Gragoudas E, Walsh S. conservative treatment of uveal melanoma: survival, local control, eye retention, and vision in patients with intermediate and large tumor after proton beam therapy. Int J Radiat Oncol Biol Phys 1994;30(supp. 1):233.
69. Munzenrider JE, Liebsch NJ. Proton therapy for tumors of the skull base. Strahlenther Onkol 1999;175(Suppl 2):57-63.
70. Muthukumar N, Kondziolka D, Lunsford LD, Flickinger JC. Stereotactic radiosurgery for chordoma and chondrosarcoma: further experiences. Int J Radiat Oncol Biol Phys 1998;41:387-92.
71. Noel G, Boisserie G, Dessard-Diana B, Ferrand R, Hasboun D, Gasowski M, et al. Comparaison par les histogrammes dose-volume de deux techniques d'irradiation conformationnelle des cancers du nasopharynx classés T4N0M0: l'une par photons et protons et l'autre par photons seuls. Cancer Radiother 2002;6:337-48.
72. Noel G, Habrand JL, Mammar H, Haie-Meder C, Pontvert D, Dederke S, et al. Highly conformal therapy using proton component in the management of meningioma: preliminary experience of the centre de protonthérapie d'Orsay. Strahlenther Onkol 2002;178:480-5.
73. Noel G, Habrand JL, Helfre S, Mammar H, Kalifa C, Ferrand R, et al. Proton beam therapy in the management of central nervous tumors in childhood: the preliminary experience of the Centre de Protonthérapie d'Orsay. Med Pediatr Oncol 2003;40:309-15.
74. Noel G, Habrand JL, Mammar H, Pontvert D, Haie-Meder C, Hasboun D, et al. Combination of photon and proton radiation therapy for chordomas and chondrosarcomas of the skull base: the Centre de protonthérapie D'Orsay experience. Int J Radiat Oncol Biol Phys 2001;51:392-8.
75. Noel G, Mammar H, Ferrand R, Desblancs C, Nauraye C, Mazeron JJ. Résultats de l'irradiation par association de photons et de protons de 47 chordomes et chondrosarcomes et de 17 méningiomes. Expérience du centre de protonthérapie d'Orsay. Rev Neurol (Paris) 2002;158:497-509.
76. Noel G, Sarrazin T, Mirabel X, Prevost B. Utilisation d'un système d'imagerie en temps réel dans le contrôle quotidien de patients traités par irradiation pour un cancer thoracique. Cancer Radiother 1997;1: 249-57.
77. Orecchia R, Zurlo A, Loasses A, Krengli M, Tosi G, Zurrida S, et al. Particle beam therapy (hadrontherapy): basis for interest and clinical experience. Eur J Cancer 1998;34:459-68.
78. Paganetti H, Niemierko A, Ancukiewicz M, Gerweck LE, Goitein M, Loeffler JS, et al. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys 2002;53:407-21.
79. Romero J, Cardenes H, la Torre A, Valcarcel F, Magallon R, Regueiro C, et al. Chordoma: results of radiation therapy in eighteen patients. Radiother Oncol 1993;29:27-32.
80. Ruark DS, Schlehaider UK, Shah JP. Chondrosarcomas of the head and neck. World J Surg 1992;16:1010-5.
81. Sailer SL, Rosenman JG, Soltys M, Cullip TJ, Chen J. Improving treatment planning accuracy through multimodality imaging. Int J Radiat Oncol Biol Phys 1996;35:117-24.
82. Saito K, Unni KK, Wollan PC, Lund BA. Chondrosarcoma of the jaw and facial bones. Cancer 1995;76:1550-8.
83. Sandler HM, McShan DL, Lichter AS. Potential improvement in the results of irradiation for prostate carcinoma using improved dose distribution. Int J Radiat Oncol Biol Phys 1992;22:361-7.
84. Santoni R, Liebsch N, Finkelstein DM, Hug E, Hanssens P, Goitein M, et al. Temporal lobe (TL) damage following surgery and high-dose photon and proton irradiation in 96 patients affected by chordomas and chondrosarcomas of the base of the skull. Int J Radiat Oncol Biol Phys 1998;41:59-68.
85. Schneider U, Lomax A, Lombriser N. Comparative risk assessment of secondary cancer incidence after treatment of Hodgkin's disease with photon and proton radiation. Radiat Res 2000;154:382-8.
86. Schoenthaler R, Fullerton B, Maas A, Collier JM, Liebsch N, Hug E, et al. Relationship between dose to auditory pathways and audiological outcomes in skull-base tumor patients receiving high-dose proton-photon radiotherapy. Int J Radiat Oncol Biol Phys 1996;36:291 (abs. 2026).
87. Schulte RW, Slater JD, Rossi Jr. CJ, Slater JM. Value and perspectives of proton radiation therapy for limited stage prostate cancer. Strahlenther Onkol 2000;176:3-8.
88. Seddon JM, Gragoudas ES, Albert DM, Hsieh CC, Polivogianis L, Friedenberg GR. Comparison of survival rates for patients with uveal melanoma after treatment with proton beam irradiation or enucleation. Am J Ophthalmol 1985;99:282-90.
89. Seifert V, Stolke D, Mehdorn HM, Hoffmann B. Clinical and radiological evaluation of long-term results of stereotactic proton beam radiosurgery in patients with cerebral arteriovenous malformations. J Neurosurg 1994;81:683-9.
90. Shields CL, Shields JA, Cater J, Lois N, Edelstein C, Gunduz K, et al. Transpupillary thermotherapy for choroidal melanoma: tumor control and visual results in 100 consecutive cases. Ophthalmology 1998;105:581-90.
91. Shipley WU, Verhey LJ, Munzenrider JE, Suit HD, Urie MM, McManus PL, et al. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys 1995;32:3-12.
92. Slater JD, Austin-Seymour M, Munzenrider J, Birnbaum S, Carroll R, Klibanski A, et al. Endocrine function following high-dose proton therapy for tumors of the upper clivus. Int J Radiat Oncol Biol Phys 1988;15:607-11.
93. Slater JD, Rossi Jr. CJ, Yonemoto LT, Reyes-Molyneux NJ, Bush DA, Antoine JE, et al. Conformal proton therapy for early-stage prostate cancer. Urology 1999;53:978-84.
94. Slater JD, Slater JM, Wahlen S. The potential for proton beam therapy in locally advanced carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1992;22:343-7.
95. Slater JM, Slater JD, Archambeau JO. Carcinoma of the tonsillar region: potential for use of proton beam therapy. Int J Radiat Oncol Biol Phys 1992;22:311-9.
96. Smit BM. Prospects for proton therapy in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1992;22:349-53.
97. Suit HD, Goitein M, Munzenrider J, Verhey L, Davis KR, Koehler A, et al. Definitive radiation therapy for chordoma and chondrosarcoma of base of skull and cervical spine. J Neurosurg 1982;56:377-85.
98. Tatsuzaki H, Urie MM, Linggood R. Comparative treatment planning: proton vs. X-ray beams against glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1992;22:265-73.
99. Tatsuzaki H, Urie MM, Willett CG. 3-D comparative study of proton vs. X-ray radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 1992;22:369-74.
100. Terahara A, Niemierko A, Goitein M, Finkelstein D, Hug E, Liebsch N, et al. Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma. Int J Radiat Oncol Biol Phys 1999;45:351-8.
101. Tsunemoto H, IshikawaT, Morita S, KitagawaT, Tsujii H. Indications of particle radiation therapy in the treatment of carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 1992;22:321-4.
102. Urie MM, Fullerton B, Tatsuzaki H, Birnbaum S, Suit HD, Convery K, et al. A dose response analysis of injury to cranial nerves and/or nuclei following proton beam radiation therapy. Int J Radiat Oncol Biol Phys 1992;23:27-39.
103. Verhey LJ, Smith V, Serago CF. Comparison of radiosurgery treatment modalities based on physical dose distributions. Int J Radiat Oncol Biol Phys 1998;40:497-505.
104. Wambersie A, Gregroire V, Brucher JM. Potential clinical gain of proton (and heavy ion) beams for brain tumors in children. Int J Radiat Oncol Biol Phys 1992;22:275-86.
105. Wenkel E, Thornton AF, Finkelstein: D, Adams J, Lyons S, De La MS, et al. Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. Int J Radiat Oncol Biol Phys 2000;48:1363-70.